TREATMENT OF CYTOMEGALOVIRUS PNEUMONITIS AFTER BONE MARROW TRANSPLANTATION WITH 9-[2-HYDROXY-1-(HYDROXYMETHYL) ETHOXYMETHYL] GUANINE
- 14 June 1986
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 327 (8494) , 1377-1378
- https://doi.org/10.1016/s0140-6736(86)91682-x
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Interstitial Pneumonitis After Bone Marrow TransplantationAnnals of Internal Medicine, 1986
- 9-(1,3-dihydroxy-2-propoxymethyl)guanine for Cytomegalovirus Infections in Patients with the Acquired Immunodeficiency SyndromeAnnals of Internal Medicine, 1985
- Activity of 9-[2-Hydroxy-1-(hydroxymethyl)ethoxymethyl]guanine in the Treatment of Cytomegalovirus PneumoniaAnnals of Internal Medicine, 1985
- Effect of 9-(1,3-dihydroxy-2-propoxymethyl)guanine on human cytomegalovirus replication in vitroAntimicrobial Agents and Chemotherapy, 1983
- 9-([2-hydroxy-1-(hydroxymethyl)ethoxy]methyl)guanine: a selective inhibitor of herpes group virus replication.Proceedings of the National Academy of Sciences, 1983